Targeting synaptic pathology in multiple sclerosis: Fingolimod to the rescue?

British Journal of Pharmacology

Volumn 165, Issue 4, 2012, Pages 858-860

  Gillingwater, Thomas H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

experimental autoimmune encephalomyelitis; fingolimod; inflammation; mouse; multiple sclerosis; neurodegeneration; neuroprotection; synapse

Indexed keywords

FINGOLIMOD;

ARTICLE; CORPUS STRIATUM; DENDRITIC SPINE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG TARGETING; EXCITATORY POSTSYNAPTIC POTENTIAL; HUMAN; MULTIPLE SCLEROSIS; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SYNAPSE;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOSUPPRESSIVE AGENTS; MICE; MULTIPLE SCLEROSIS; PROPYLENE GLYCOLS; SPHINGOSINE; SYNAPSES;

EID: 84856269823     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01612.x     Document Type: Article

References (18)

1. Brinkmann V, (2009). FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system. Br J Pharmacol 158: 1173-1182.
2. Centonze D, Muzio L, Rossi S, Cavasinni F, De Chiara V, Bergami A, et al,. (2009). Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci 29: 3442-3452.
3. Cohen JA, Chun J, (2011). Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis. Ann Neurol 69: 759-777.
4. Coleman P, Federoff H, Kurlan R, (2004). A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology 63: 1155-1162. (Pubitemid 39350010)
5. Compston A, Coles A, (2008). Multiple sclerosis. Lancet 372: 1502-1517.
6. Dutta R, Trapp BD, (2011). Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol 93: 1-12.
7. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, et al,. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 185: 232-240. (Pubitemid 38084849)
8. Hensley K, (2010). Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation. J Alzheimers Dis 21: 1-14.
9. Khatri B, Barkhof F, Comi G, Hartung HP, Kappos L, Montalban X, et al,. on behalf of the TRANSFORMS Study Group (2011). Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. Lancet Neurol 10: 520-529.
10. Mandolesi G, Grasselli G, Musumeci G, Centonze D, (2010). Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration. Neurol Sci 31: S255-S259.
11. Murray LM, Comley LH, Thomson D, Parkinson N, Talbot K, Gillingwater TH, (2008). Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum Mol Genet 17: 949-962. (Pubitemid 351426029)
12. Papadimitriou D, Le Verche V, Jacquier A, Ikiz B, Przedborski S, Re DB, (2010). Inflammation in ALS and SMA: sorting out the good from the evil. Neurobiol Dis 37: 493-502.
13. Pitt D, Werner P, Raine CS, (2000). Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6: 67-70. (Pubitemid 30048528)
14. Rossi S, Lo Giudice T, De Chiara V, Musella A, Studer V, Motta C, et al,. (2011). Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis. Br J Pharmacol 165: 861-869.
15. Smith T, Groom A, Zhu B, Turski L, (2000). Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 6: 62-66. (Pubitemid 30048527)
16. Sriram S, Steiner I, (2005). Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann Neurol 58: 939-945. (Pubitemid 41746884)
17. Wishart TM, Parson SH, Gillingwater TH, (2006). Synaptic vulnerability in neurodegenerative disease. J Neuropathol Exp Neurol 65: 733-739. (Pubitemid 44200314)
18. Zhu B, Luo L, Moore GR, Paty DW, Cynader MS, (2003). Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis. Am J Pathol 162: 1639-1650. (Pubitemid 36512847)